Emory Vaccine and Treatment Evaluation Unit - DMID 21-0002

NIH Pandemic-Era Grants

Pandemic Era Grants

2021

↗ Live URL (may be dead)

Document text

Principal Investigator: EVAN J ANDERSON
Organization: EMORY UNIVERSITY
Fiscal Year: 2021
Award: $655,337
Funding agency: National Institute of Allergy and Infectious Diseases

Summary/Abstract
The Emory VTEU has proven essential in the fight against the pandemic. This supplement will
allow for further investigations into vaccines trials (21-0002).
1

Terms: <2019-nCoV variant><2019-nCoV variant forms><2019-nCoV variant strains><21+ years old><Adult><Adult Human><COVID-19 variant><COVID-19 variant forms><COVID-19 variant strains><Evaluation><Investigation><Moderna COVID-19 vaccine><Moderna coronavirus disease 2019 vaccine><Phase><Randomized><SARS-CoV-2 variant><SARS-CoV-2 variant forms><SARS-CoV-2 variant strains><Vaccinated><Vaccines><adulthood><coronavirus disease 2019 variant><coronavirus disease 2019 variant forms><coronavirus disease 2019 variant strains><fight against><immunogenicity><mRNA-1273><mRNA1273><open label><open label study><pandemic><pandemic disease><randomisation><randomization><randomly assigned><safety study><severe acute respiratory syndrome coronavirus 2 variant><severe acute respiratory syndrome coronavirus 2 variant forms><severe acute respiratory syndrome coronavirus 2 variant strains><vaccination study><vaccination trial><vaccine study><vaccine trial>